Compliance Rate
Compliance Rate
50.0%
Compliant submissions
2
Incompliant submissions
2
Total trials
4
My Organizations' Clinical Trials
Showing 400 of 1308 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 04/15/18
End: 11/30/20
Due: 11/30/21
Phase: N/A
Priority: Normal
Start: 03/25/25
End: 04/01/26
Due: 04/01/27
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 03/01/19
Due: 03/01/20
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 02/28/15
Due: 02/28/16
Enhancing Management of Chronic Pain and Symptoms Among Women Treated for Breast Cancer (Lymph-Flow)
Phase: N/A
Priority: Normal
Start: 05/01/15
End: 12/01/16
Due: 12/01/17
Phase: N/A
Priority: Normal
Start: 10/01/19
End: 08/01/23
Due: 08/01/24
Phase: N/A
Priority: Normal
Start: 08/01/18
End: 10/05/18
Due: 10/05/19
Phase: N/A
Priority: Normal
Start: 09/30/06
End: 02/28/11
Due: 02/28/12
Phase: N/A
Priority: Normal
Start: 09/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 12/08/21
Due: 12/08/22
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 04/13/17
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 05/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 06/27/14
End: 12/24/20
Due: 12/24/21
Phase: N/A
Priority: Normal
Start: 04/04/19
End: 06/30/21
Due: 06/30/22
Phase: N/A
Priority: Normal
Start: 03/07/18
End: 05/08/24
Due: 05/08/25
Phase: N/A
Priority: Normal
Start: 05/08/19
End: 03/23/20
Due: 03/23/21
Phase: N/A
Priority: Normal
Start: 06/12/20
End: 03/26/21
Due: 03/26/22
Phase: N/A
Priority: Normal
Start: 05/07/18
End: 07/17/20
Due: 07/17/21
Phase: N/A
Priority: Normal
Start: 04/30/94
End: -
Due: -